The integrated pathway involving TGF-β/Snail with TNFα/NFκB may be the principal axis that associates cancer cells to their microenvironment during the EMT process and exerts a critical role in CRC development and prognosis, which results in a poor prognosis for patients [43]. The gene discussed is TGFB1; the disease is cancer.